As of June 03, 2025, Cellectis S.A. (ALCLS.PA) has a market cap of $0.15 billion USD. According to our data, Cellectis S.A. is ranked No.7321 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $0.15 B |
13.71%
|
Dec 31, 2024 | $0.13 B |
-41.03%
|
Dec 29, 2023 | $0.23 B |
39.10%
|
Dec 30, 2022 | $0.16 B |
-73.29%
|
Dec 31, 2021 | $0.62 B |
-69.51%
|
Dec 31, 2020 | $2.02 B |
55.61%
|
Dec 31, 2019 | $1.30 B |
3.98%
|
Dec 31, 2018 | $1.25 B |
-36.74%
|
Dec 29, 2017 | $1.97 B |
47.07%
|
Dec 30, 2016 | $1.34 B |
-42.21%
|
Dec 30, 2015 | $2.32 B |
129.35%
|
Dec 31, 2014 | $1.01 B |
431.74%
|
Dec 31, 2013 | $0.19 B |
-66.91%
|
Dec 28, 2012 | $0.58 B |
9.79%
|
Dec 30, 2011 | $0.52 B |
-12.08%
|
Dec 30, 2010 | $0.60 B |
-30.50%
|
Dec 31, 2009 | $0.86 B |
49.06%
|
Dec 31, 2008 | $0.58 B |
-22.78%
|
Dec 31, 2007 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.69 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.16 B |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.10 M |
0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.43 B |
-0.000 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.53 B |
-0.000 M
|
![]() USA
|
Market Cap | = | ALCLS.PA Stock Price | * | ALCLS.PA Shares Outstanding |
= | $1.53 | * | 72.29 M | |
= | $0.15 B |